Cyclenium Pharma Inc
Cyclenium Pharma Inc, based in Montréal, Québec, is the Canadian Subsidiary of SpiroChem AG, specializing in utilizing its proprietary CMRT™ small-molecule macrocycle technology for drug discovery against challenging disease targets. As a Contract Research Organization, Cyclenium provides solutions to pharmaceutical and biotechnology companies globally, enabling exploration of macrocycles as innovative modalities.
Founded by experts from Tranzyme Pharma, pioneers in small molecule macrocycles for drug discovery, Cyclenium boasts a profound knowledge base in macrocyclic chemistry, developed from the generation and optimization of lead candidates that progressed to late-stage clinical trials. Their cutting-edge technology addresses previous limitations in the field, offering customers access to a revolutionary platform for drug discovery.
Over the years, Cyclenium has achieved significant milestones, including collaborations with prominent organizations like Vuja De Sciences, AiCuris, and Ono Pharmaceutical, showcasing their expertise in areas such as anti-infective pharmaceuticals and pan-flaviviral therapeutics. With a team led by experienced professionals like CEO & CSO Thomas Fessard and Executive Director of Medicinal Chemistry Arkadii Vaisburg, Cyclenium continues to drive innovation in pharmaceutical research and development.
Generated from the website content
Also at this address
You might also like
Partial Data by Foursquare.